Overview of clinical, molecular, and therapeutic features of Niemann–Pick disease (types A, B, and C): Focus on therapeutic approaches
Cell Biochemistry and Function · 2024-06 · 42 (4)
DOI: 10.1002/cbf.4028 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, published online on 2024-05-07. Written by Kamran Hosseini and 5 co-authors. Institution: Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. Major MEDLINE topics: Genetic Therapy, Mutation, Niemann-Pick C1 Protein. Cited 14 times so far (Crossref); 156 references.
Abstract (original language)
Niemann–Pick disease (NPD) is another type of metabolic disorder that is classified as lysosomal storage diseases (LSDs). The main cause of the disease is mutation in the SMPD1 (type A and B) or NPC1 or NPC2 (type C) genes, which lead to the accumulation of lipid substrates in the lysosomes of the liver, brain, spleen, lung, and bone marrow cells. This is followed by multiple cell damage, dysfunction of lysosomes, and finally dysfunction of body organs. So far, about 346, 575, and 30 mutations have been reported in SMPD1 , NPC1 , and NPC2 genes, respectively. Depending on the type of mutation and the clinical symptoms of the disease, the treatment will be different. The general aim of the current study is to review the clinical and molecular characteristics of patients with NPD and study various treatment methods for this disease with a focus on gene therapy approaches.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Molecular Medicine, Faculty of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
- Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Zand Institute of Higher Education, Shiraz, Iran.
- Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Cite
APA
Hosseini, K., Fallahi, J., Razban, V., Sirat, R. Z., Varasteh, M., & Tarhriz, V. (2024). Overview of clinical, molecular, and therapeutic features of Niemann–Pick disease (types A, B, and C): Focus on therapeutic approaches. Cell Biochemistry and Function, 42(4). https://doi.org/10.1002/cbf.4028
Vancouver
Hosseini K, Fallahi J, Razban V, Sirat RZ, Varasteh M, Tarhriz V. Overview of clinical, molecular, and therapeutic features of Niemann–Pick disease (types A, B, and C): Focus on therapeutic approaches. Cell Biochemistry and Function. 2024;42(4). doi:10.1002/cbf.4028
BibTeX
@article{Hosseini2024,
author = {Hosseini, Kamran and Fallahi, Jafar and Razban, Vahid and Sirat, Reyhaneh Zayyani and Varasteh, Mahnaz and Tarhriz, Vahideh},
title = {Overview of clinical, molecular, and therapeutic features of Niemann–Pick disease (types A, B, and C): Focus on therapeutic approaches},
journal = {Cell Biochemistry and Function},
year = {2024},
volume = {42},
number = {4},
doi = {10.1002/cbf.4028}
}
EUVIMED